Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SQ109 EBA Trial in Pulmonary TB
NCT01218217Phase 2Completed
- Start
- Nov 2010
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SQ109 in pulmonary tuberculosis (TB). Started Nov 2010; status: completed.
02
Drugs
SQ109
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT01218217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01218217.